Cargando…

Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals

Mostrar otras versiones (1)

The association between COVID-19 symptoms and antibody responses against SARS-CoV-2 is poorly characterized. We analyzed antibody levels in individuals with known SARS-CoV-2 infection to identify potential antibody-symptom associations. Convalescent plasma from 216 SARS-CoV-2 RNA+ individuals with s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saraf, Sharada, Zhu, Xianming, Shrestha, Ruchee, Bonny, Tania S., Baker, Owen R., Beck, Evan J., Fernandez, Reinaldo E., Eby, Yolanda, Akinde, Olivia, Ruff, Jessica E., Caturegli, Patrizio, Redd, Andrew D., Bloch, Evan M., Quinn, Thomas C., Tobian, Aaron AR, Laeyendecker, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845513/ https://www.ncbi.nlm.nih.gov/pubmed/35169815 http://dx.doi.org/10.1101/2022.02.09.22270718

Ejemplares similares

Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals
por: Saraf, Sharada, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
por: Benner, Sarah E, et al.
Publicado: (2020)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Absence of pathogenic viruses in COVID‐19 convalescent plasma
por: Kandathil, Abraham J., et al.
Publicado: (2022)

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
por: Klein, Sabra, et al.
Publicado: (2020)

CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
por: Redd, Andrew D, et al.
Publicado: (2021)

Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals
por: Redd, Andrew D, et al.
Publicado: (2021)

CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants
por: Redd, Andrew D, et al.
Publicado: (2021)

Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8(+) T-Cell Epitopes Identified in COVID-19 Convalescent Individuals
por: Redd, Andrew D., et al.
Publicado: (2022)

CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation
por: Kared, Hassen, et al.
Publicado: (2020)

LB-18. Broad and Prevalent SARS-CoV-2 CD8+ T Cell Response in Recovered COVID-19 Individuals Demonstrates Kinetics of Early Differentiation
por: Kared, Hassen, et al.
Publicado: (2020)

A Hemagglutination-Based Semiquantitative Test for Point-of-Care Determination of SARS-CoV-2 Antibody Levels
por: Kruse, Robert L., et al.
Publicado: (2021)

Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
por: Natarajan, Harini, et al.
Publicado: (2021)

SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
por: Natarajan, Harini, et al.
Publicado: (2020)

Promoting access to COVID-19 convalescent plasma in low- and middle-income countries
por: Bloch, Evan M., et al.
Publicado: (2021)

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing
por: Conklin, Steven E., et al.
Publicado: (2021)

Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department
por: Beck, Evan J, et al.
Publicado: (2021)

Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
por: Morgenlander, William, et al.
Publicado: (2020)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
por: Patel, Eshan U., et al.
Publicado: (2020)

High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
por: Li, Maggie, et al.
Publicado: (2022)

Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department
por: Laeyendecker, Oliver, et al.
Publicado: (2021)

The feasibility of multiple units of convalescent plasma in mechanically ventilated patients with COVID-19: A pilot study
por: Merin, Noah M., et al.
Publicado: (2022)

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department
por: Beck, Evan J., et al.
Publicado: (2022)

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
por: Patel, Eshan U., et al.
Publicado: (2021)

Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
por: Bloch, Evan M, et al.
Publicado: (2021)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
por: Li, Maggie, et al.
Publicado: (2022)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
por: McConnell, Scott A., et al.
Publicado: (2023)

Sequential dosing of convalescent COVID-19 plasma with significant temporal clinical improvements in a persistently SARS-COV-2 positive patient
por: Mirihagalle, Noupama, et al.
Publicado: (2021)

Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2021)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Public Knowledge and Attitudes Toward Clinical Trials in the COVID-19 Era
por: Patel, Eshan U., et al.
Publicado: (2022)

Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018
por: Goel, Ruchika, et al.
Publicado: (2021)

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
por: Karaba, Andrew H., et al.
Publicado: (2022)

Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations
por: Park, Han-Sol, et al.
Publicado: (2023)

Disease prevalence in a rural Andean population of central Peru: a focus on autoimmune and allergic diseases
por: Caturegli, Giorgio, et al.
Publicado: (2016)

Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment
por: Karaba, Andrew H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_in6v0flp9d1j38a7trbe9ruqsq